Death and severe morbidity in isolated periviable small-for-gestational-age fetuses
- PMID: 35437890
- DOI: 10.1111/1471-0528.17181
Death and severe morbidity in isolated periviable small-for-gestational-age fetuses
Abstract
Objective: This study aims to predict perinatal death or severe sequelae in isolated small-for-gestational-age fetuses, diagnosed at a periviable gestational age, based on ultrasound and Doppler parameters at diagnosis.
Design: Observational study.
Setting: A tertiary perinatal centre.
Population: A cohort of singleton non-malformed fetuses suspected to be small for gestational age (estimated fetal weight, EFW, <10th centile) diagnosed at 22.0-25.6 weeks of gestation. The following parameters were recorded at diagnosis: severe smallness (<3rd centile); absent or reversed end-diastolic velocity in umbilical artery; abnormal middle cerebral artery Doppler; abnormal cerebroplacental ratio; abnormal uterine artery Doppler; and absent or reversed end-diastolic velocity in the ductus venosus.
Methods: Logistic regression analysis.
Main outcome measures: Predictive performance of EFW and Doppler parameters for short-term adverse outcome of perinatal morbimortality and composite serious adverse outcomes (death, neurological impairment or severe bronchopulmonary dysplasia).
Results: A total of 155 pregnancies were included. There were 13 (8.4%) intrauterine and 11 (7.7%) neonatal deaths. A short-term adverse perinatal outcome occurred in 40 (25.8%) pregnancies. There were 31 (20%) cases of serious adverse outcomes. For the prediction of serious adverse outcomes, the combination of absent or reversed end-diastolic velocity in the umbilical artery and impaired middle cerebral artery detected by Doppler evaluation achieved a detection rate of 87%, with a false-positive rate of 14% (accuracy 86%).
Conclusion: In periviable isolated small-for-gestational-age fetuses, a Doppler evaluation of the umbilical and fetal brain circulation can accurately predict short-term adverse perinatal complications and serious adverse outcomes.
Keywords: fetal growth restriction; neonatal complications; neurological impairment; perinatal mortality; placental insufficiency; small for gestational age.
© 2022 John Wiley & Sons Ltd.
Comment in
-
A combination of clinical Doppler ultrasound and angiogenic biomarker assessment is currently the best approach for the evaluation of periviable fetal growth restriction.BJOG. 2023 May;130(6):687-688. doi: 10.1111/1471-0528.17352. Epub 2022 Dec 8. BJOG. 2023. PMID: 36482166 No abstract available.
References
REFERENCES
-
- Anandakumar C, Chew S, Wong YC, Malarvishy G, Po LU, Ratnam SS. Early asymmetric IUGR and aneuploidy. J Obstet Gynaecol Res. 1996;22(4):365-70.
-
- Meler E, Sisterna S, Borrell A. Genetic syndromes associated with isolated fetal growth restriction. Prenat Diagn. 2020;40(4):432-46.
-
- Lawin-O'Brien AR, Dall'Asta A, Knight C, Sankaran S, Scala C, Khalil A, et al. Short term outcome of periviable SGA: is our counseling up to date? Ultrasound Obstet Gynecol. 2016;48(5):636-41.
-
- Dall'Asta A, D'Antonio F, Saccone G, Buca D, Mastantuoni E, Liberati M, et al. Cardiovascular events following pregnancies complicated by preeclampsia with emphasis on the comparison between early and late onset forms: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2020;56:287. https://doi.org/10.1002/uog.22107
-
- Groom KM, David AL. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction. Am J Obstet Gynecol. 2018;218(2S):S829-40.
Publication types
MeSH terms
Grants and funding
- 2017 SGR grant n 1531/AGAUR
- Cerebra Foundation for the Brain Injured Child
- SLT008/18/00156/Departament de Salut
- Fondo Europeo de Desarrollo Regional (FEDER)
- PIE15/00027/Instituto de Salud Carlos III
- CM19/Instituto de Salud Carlos III
- CM19/00140/Instituto de Salud Carlos III
- PI14/00226/Instituto de Salud Carlos III
- PI16/00861/Instituto de Salud Carlos III
- PI18/00073/Instituto de Salud Carlos III
- PI19/01872/Instituto de Salud Carlos III
- LCF/PR/GN18/10310003/La Caixa Foundation
- INPHRET_19_005/La Caixa Foundation
- LCF/PR/GN14/10270005/La Caixa Foundation
LinkOut - more resources
Full Text Sources